Among the subjects with metastatic colorectal cancer (mCRC), the carriers of any G allele in CCL5 rs2280789, who had received cetuximab plus FOLFIRI, demonstrated shorter OS when compared to AA homozygotes [47]. The gene discussed is CCL5; the disease is metastatic colorectal cancer.